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ABSTRACT
Bioimpedance analysis (BIA) is a method of detecting lymphedema- a debilitating
medical condition involving swelling of the extremities. Pneumatic compression devices are
frequently used in the compression treatment of lymphedema. Although existing compression
technology provides relief of symptoms, it has limitations in terms of ease-of-use, portability,
and monitoring of treatment progress. Currently, there are no BIA analyzers in the market that
run on a low-power microcontroller and a rechargeable battery. Moreover, no such device
currently exists that integrate the BIA analysis with pneumatic compression system to offer a
feedback-based solution for lymphedema treatment. This work represents the first steps towards
a complete system and describes the pneumatic compression and circuit designs for a portable
BIA analyzer. The study proposes a lightweight, battery operated pneumatic compression device
that can apply a pressure of 50 mmHg in a four-chamber compression garment. A
microcontroller-based BIA system that can provide accurate indication of swelling based on a
Nyquist plot was introduced. The envisioned mechatronic system features programmable
compression sequences and operates with the human-in-the-loop using bioimpedance
spectroscopy as control feedback. Performance of the compression system is verified by
measurement of applied pressures and the BIA circuits are validated for single frequency and
multi frequency impedance analysis of a phantom test load. With further development in the
future, the system has the potential to serve as a quantitative source of valuable diagnostic
information for clinicians, and in the long run may enable the smart management of lymphedema
with the device essentially prescribing the course of treatment in response to measured
conditions. This kind of human-in-the-loop control system may be a breakthrough in treatment of
chronic conditions.
vi

INTRODUCTION
Lymphedema is a condition (or set of conditions) where excessive interstitial protein-rich
fluid is accumulated in particular limb(s) of the body [1]. It occurs when there is an imbalance
between the lymphatic flow and lymphatic circulation. In other words, when the lymphatic
system cannot provide enough circulation of lymphatic flow, the affected limb(s) can suffer from
chronic conditions like swelling, aching, heaviness, and impaired freedom of movement, Figure
1.1. Additionally, skin infections such as cellulitis are common in lymphedema.

Figure 1.1. Schematic of a typical case of lymphedema- causing swelling in the right arm.
In addition to swelling and other associated discomforts, lymphedema can greatly affect
quality of life and the perception of well-being [2]. Several psychological issues such as
depression, anxiety, and isolation are manifested by patients with lymphedema [3]–[5]. Studies
suggest that women suffering from breast cancer related lymphedema showed less compliance
with available treatments due to those psychological factors [4], [5].
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LYMPHATIC SYSTEM
To understand lymphedema, it is important to understand the lymphatic system in the
body. The lymphatic system is a large network of lymph vessels, lymphoid tissues, and a
circulating clear fluid called ‘lymph’. The lymphatic system removes excess fluid and waste
from the body tissues and returns it to the bloodstream. It also helps to absorb fat and fat-soluble
vitamins from the digestive system. The primary function of the lymph vessels is to carry the
lymph throughout the body, Figure 1.2.

(a) Schematic of distribution of lymph nodes in the upper extremity.
(figure cont’d)
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(b) Structure of a lymph node (Courtesy of OpenStax College 2014) [6] .
Figure 1.2. The lymphatic system of a human body.
Lymph contains waste products and cellular debris that need to be filtered from
bloodstream [7]. A large number of lymph nodes (around 500-600) distributed throughout the
body by lymphatic vessels act as a filter for these waste products and debris. If there are signs of
an infection, the body makes excess lymphocytes (white blood cells) to fight that infection.
When the number of lymphocytes increases, the lyph nodes along the lymph vessels that drain
the infected area swell. A typical example would be an infection in the throat that causes the
lymph nodes in the neck to swell.
The functional units of a lymphatic vessel is called lymphangions. They are nestled
between two lymph valves and play a major role in pumping lymph fluid by cyclically
contracting and relaxing the lymphatic muscles Figure 1.3. The amount of lymph fluid pumped
by lymphangions is governed by factors like lymphangion length, contraction frequency of
lymphatic muscles, and external pressure [8]. The lymph valves are directed toward the direction
of lymph flow as seen in Figure 1.3.
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Figure 1.3. Schematic of a lymphangion chain network.
In an effectively working lymphatic system, the valves open when the pressure in the first
lymphangion is higher than in the next lymphangion. Once the lymph flows to the next
lymphangion, the valve closes tightly, hence allowing only a unidirectional flow. In the case of
lymphedema, the pressure in a lymphatic system is much higher than a normal lymphatic system
due to the excess interstitial fluid. As a result, the lymphatic valves fail to function properly and
the unidirectional lymph flow gets disrupted. This results in a much lower outflow of lymph fluid
from the system- an indication of lymphedema.

TYPES OF LYMPHEDEMA
Lymphedema can be classified as primary and secondary. Primary lymphedema is a rare
and inherited condition caused by defective lymph vessels in the body. Secondary lymphedema,
which is more common than the primary form, is caused by disruption of lymphatic pathways as
a consequence of a surgery that typically involves removal of lymph nodes [9]. When lymphatic
tissues or lymph nodes are removed, the lymph cannot be drained efficiently from the affected
area. As a consequence, excess lymph accumulates and causes swelling.
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In the last 45 years, the global occurrence of secondary lymphedema has increased by 4
times [1], [10]. In USA, nearly 1 in every 1000 people are suffering from secondary
lymphedema, Figure 1.4. Lymphedema can occur in both the upper and the lower extremities of
the body. In the USA, the most common form of secondary lymphedema is the edema of the
arm. Typically this is caused by axillary lymph node (around the armpit) dissection as a part of
breast cancer surgery [11]. The incidence of lymphedema after breast cancer surgery may be as
high as 70% [12].

Number of Secondary
Lymphedema Cases

1,000,000,000

250,000,000

100,000,000
10,000,000
450000

1,000,000
100,000
10,000
1,000
Global

USA

Figure 1.4. Number of secondary lymphedema cases- Global vs USA.

LYMPHEDEMA MEASUREMENTS
For the measurement of lymphedema, a non-invasive technique called bio impedance
analysis (BIA) is used to monitor changes in total body water (TBW), extra-cellular fluid (ECF),
intra-cellular fluid (ICF), fat mass, and fat free mass. By sending a low-level AC current through
the body, the resistance and reactance are measured. At very low frequency, the current cannot
pass throught the cell walls, allowing the measurements of only extra-cellular fluid (ECF)
impedance, Figure 1.5. Conversely, at very high frequencies, the current can pass through the
5

cell walls, allowing the measurements of total body water (TBW) impedance. The intra-cellular
fluid (ICF) impedance can be obtained by subtracting the ECF impedance from the TBW
impedance. Furthermore, the ECF and ICF impedance can be used to calculate fat mass and fatfree mass.
Cell Membrane
Intra-Cellular
Fluid (ICF)
Extra-Cellular
Fluid (ECF)

High Frequency Current

Low Frequency Current

Figure 1.5. Low and high frequency current flow in body cells.
Bio impedance spectroscopy (BIS) analysis is the most advanced form of BIA which
measures fluid and tissue volume that gives an accurate indication of lymphedema. The
technique is capable of detecting lymphedema symptoms by measuring the change in ECF in the
body [13]. Typically, a Nyquist plot of the body component’s electrical transfer function is
obtained by plotting real and imaginary impedance (ex. resistance and reactance) of the body for
a sweep of test frequencies. A mixture model of the tissue indicates that quantities of
extracellular water and total water correspond to impedance measured at a very low (zero)
frequency and a very high (infinite) frequency, respectively [14].

LYMPHEDEMA TREATMENTS
Lymphedema is a chronic condition that needs continuous and meticulous care. Complete
decongestive physiotherapy (CDP) is an effective option for the initial treatment of lymphedema.
The treatment includes manual lymphatic drainage (MLD), compression stockings and bandages,
and pneumatic compression [15]. Study suggests that patients who showed compliance with
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CDP had an average reduction of 59% in upper extremity volume on a 9 month follow-up [16].
However, CDP involves care by a trained specialist in a clinical setting and therefore it cannot be
sustained forever. Patients must eventually transition into self-care in an at-home setting [17].
Use of compression devices as a part of CDP showed reduced limb volume and improved
lymphatic function [18], [19]. Recent guidelines suggest using pneumatic compression devices
for 1 hour per day with maximum pressure ranging from 30 mmHg to 60 mmHg [19]. A typical
pneumatic compression device consists of a compression garment having single or multiple
chambers and a pneumatic pump, Figure 1.6. A multi-chamber compression garment allows
calibrated gradient pressure in the chambers, targeting specific areas for compression [20]. The
pneumatic pumps apply sequential pressure that varies along the length of the treatment area
(upper or lower extremity) and over time, which is categorized as dynamic therapy. This kind of
therapy is designed to stimulate fluid circulation through open channels and improve conditions
for uptake of fluid into the lymphatics.

Figure 1.6. A traditional pneumatic compression device with a pneumatic pump and
multi-chamber compression garment.
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DESIGN REQUIREMENTS
The regular and compliant compression treatment for lymphedema requires a
compression device that is able to apply sufficient pressure to cause movement of lymph fluid. A
minimum of 30 mmHg pressure needs to be maintained by a prefabricated or custom-fabricated
compression garment to be classified as a compression treatment device [21]. In case of a
gradient pressure (from lowest to highest pressure point) the applied pressure needs to be
sufficient to move lymph fluid from distal to proxima or vice versa. Additionally, no tourniquet
effect should be observed at any point during the compression treatment. For inflation of a
multichamber compression garment, the time of inflation needs to be sufficient for translocation
of lymph fluid in proximal region [22]. A typical sequential pneumatic comression pump can
weigh around 5 lbs with the applied pressure as high as 125 mmHg [23].
The compression garment should be designed such a way that prevents skin infection and
allows as much freedom of movement as possible [24]. The garment should not be too tight and
should be able to provide a firm support. A clinical decision-making is required to determine the
firmness of the fabric on the skin of an individual. The garment should be able to withstand
frequent washing, exposure to sun, and stretching from donning and doffing, and be able to
provide effective compression for four to six months [25].
A BIA analysis device should be able to determine the following three pure resistances in
the body [26]•

Resistance at zero (very low) frequency that indicates free fluid outside of body cells

•

Intra-cellular fluid (ICF) resistance that indicates intra-cellular fluid inside of body cells

•

Resistance at infinite (very high) frequency that indicates total body water (TBW)
including fluid inside of body cells
8

The range of frequency used for a BIS analysis can vary widely. However a wide frequency band
(ex. 3 kHz to 1000 kHz) typically provides a more accurate information on tissue properties.

PROBLEM STATEMENT
There are a number of companies that manufacture pneumatic compression devices for
lymphedema. Tactile medical and Bio Compression Systems Inc. are two of the major
manufacturers of such products. The Flexitouch system provided by Tactile medical is based on
the stimulation of lymphatic system that helps with lymphatic function improvement [27]. Bio
Compression Systems Inc. manufactures compression pumps based on intended use such as
primary and secondary lymphedema, and chronic venous stasis ulcers.
Although the intermittent pneumatic compression (IPC) shows a significant 12%
reduction in swelling for upper extremity lymphedema [28], the current compression treatment
options require patients to wear a bulky and uncomfortable compression garment and be tethered
to a stationary pneumatic pump during the duration of the process. This can greatly interfere with
the daily living of the patients. Moreover, no such device currently exists that couple the BIS
analysis with compression devices to monitor treatment progress over time and provide
feedback. Thus, the existing compression technology has limitations in terms of ease-of-use,
portability, and monitoring of treatment progress.

RESEARCH OBJECTIVES
A feedback-based portable compression system that monitors the progress and adjust
treatment courses may provide a better solution to lymphedema management. The use of a BIA
system to regulate compression and treatment duration can substantially reduce the physical
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concerns associated with this disease. A compression garment that is less obtrusive and easy to
wear can provide greater comfort to the treatment and improve psychological and functional
well-being of a person. The ability to quantify the condition can also provide substantial
motivation for the user to comply with therapy, an effect associated with the idea of the
“Quantified Self” [29]. The long-term benefit of such technology can provide a reduced risk of
infection and chronic condition.
This research introduces the concept of a smart pneumatic system that provides dynamic
compression therapy. As an initial approach, the work aimed at producing a simulation of
lymphatic network system in the upper body. Once this was accomplished, the work focused on
developing a light-weight, battery operated pneumatic compression device that can apply
compression in an ‘easy to wear’ compression garment for upper extremity (arm) lymphedema.
Another objective of current work was to propose a custom-designed BIA measurement system
that can provide impedance measurements of a human arm in a battery-powered device. Finally,
the research aimed at integrating the subsystems into a single unit to create a portable and
convenient solution for lymphedema treatment.
This thesis has three main research objectives:
1. Produce a simulation model demonstrating the effect and mechanism of pumping
action generated by external pressure variations applied to the lymphatic network.
2. Design and develop a light-weight, battery-operated pneumatic compression device
that applies compression in an easy to wear garment for upper extremity (arm)
lymphedema.
3. Design a custom, low-cost bioimpedance analysis measurement system to facilitate
estimation of the swelling state of the upper arm in a portable, battery-powered device

10

aimed at supporting the future development of a feedback control system for
treatment of lymphedema.

EXPERIMENTAL APPROACH
The general research approach to fulfill the objectives of this study is presented in Figure
1.7. An experimental program was developed for a compression subsystem and a BIA
subsystem. The development of compression subsystem included the design and development of
compression garment and pneumatic pumps. Once developed, the components of the
compression subsystem were integrated and tested for sequential pneumatic compression. The
development of BIA subsystem included the design of a test circuit for single frequency and
multi frequency BIA measurements. The circuit performance was validated using a benchtop
LCR meter. Finally, the findings from both subsystems were analyzed for discussion followed by
recommendations for future work.
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Figure 1.7. General layout of research approach.
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MATERIALS AND METHODS
MODELING THE LYMPHATIC SYSTEM
An early work on modeling the lymphatic system was performed by Reddy et al. in 1975
[30]. They presented a mathematical model of the whole-body lymphatic network that analyzed
the characteristics of lymphatic contractility at various points. Drake et al. presented the
equivalent circuit technique for lymph flow studies in 1986 [31]. They applied circuit analysis
techniques to model and analyze the lymphatic systems. The equivalent circuit consisted of a
single resistor in series with a single pressure source with the lymphatic valves represented by
diodes.
To gain an understanding of the mechanisms of action by which external compression
therapy may aid in the pumping of lymph and reduction of lymphedema-related swelling, we
investigated the effect of external pressure modulations on an existing mathematical model of a
lymphangion first presented by Bertram et al. [32]. The model is a lumped-parameter model
which includes the effects of stretch in the lymphangion walls (fluid capacitance); the HagenPoiseuille resistance to flow due to fluid viscosity (linear fluid resistance); the nonlinear diodelike behavior of valves present in the lymphangion network (nonlinear fluid resistance); the
active muscle contractions that normally exist in lymphangions (pressure sources); and the
presence of varying fluid pressure at the ends of a lymphangion chain and in the vicinity of each
lymphangion unit (pressure sources) [8]. The parameter lumping strategy associates the
lymphangion body with two fluid resistance elements and a nonlinear capacitance combined with
an active pressure source.
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Four individual lymphangions were connected in series to create a branching network
structure, Figure 2.1. A number of contractile vessel segments with diameter Di linked by valves
(i = 1, 2, 3, 4) formed the series chain that began at a reservoir of a constant pressure pa and
ended at a higher pressure pb . Each vessel segment was subject to an external pressure pei and
gave rise to an inlet pressure pi1 , a midpoint pressure pim , and an outlet pressure pi2 . With the
pressure gradient across the vessel wall defined as the transmural pressure ptm , the midpoint
pressure pim was obtained from the following equationpim = pei + ptm

(1)

Figure 2.1. Hydraulic schematic of a lymphatic system with four lymphangions
connected in series.
The flow rate (Qi ) is a function of the valve resistance (R vi ) that varied with applied
pressure difference across the valve (∆pvi) based on the following relationship-

Qi =

∆pvi
R vi

The valve resistance (R vi ) can be obtained by the following equation-
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(2)

R vi = R vn + R vx [

1
1 + exp (sopen (∆pvi − popen ))

+

1
1 + exp(−sfail (∆p − pfail ))

(3)
− 1]

Here, R vn and R vx are the minimum and maximum valve resistances determined by valve
opening slope (sopen ), valve opening pressure (popen ), valve failure slope (sfail ), and valve
failure pressure (pfail ).
Each vessel segment can be further described by the following relationship based on the
conservation of fluid massdDi
2
=
(Q − Qi+1 )
dt
πDi L i
Here,

dDi
dt

(4)

is the change in vessel diameter over time (t) and L is the lymphangion length. The

flow inside the lymphatic vessels had a fluid viscosity (μ) that characterized the linear flow
resistance (R L ), given by the following equationRL =

64μL
πDi

(5)

4

A vessel wall constitutive relation including passive and periodic contractile components
was used to obtain the following time-varying relationship between the transmural pressure
(ptm ), maximum active tension (M), contraction frequency (f), and vessel diameter (Di )ptm = Φ(Di ; Pdi , Ddi ) + 𝐴(𝑡, 𝐷𝑖 ; 𝑀, 𝑓, 𝑡0𝑖 )
Di

Φ(Di ; Pdi , Ddi ) = Pdi (eDdi − (

𝐴(𝑡, 𝐷𝑖 ; 𝑀, 𝑓, 𝑡0𝑖 ) =

Ddi 3
) )
Di

M
(1 − cos(2πf(t − t 0i )))
Di

(6a)
(6b)

(6c)

Here, Φ is the constitutive relation for the nonlinear fluid capacitance representing the stretch of
the lymphangion wall and 𝐴 is the active tension. Pdi and Ddi are constitutive relation parameter
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values, and t 0i is the start time of the active tension which sets the phase of the lymphangion
contraction relative to the other lymphangions in the network.
For each lymphangion valve, the above equations were solved computationally by using
MATLAB Simulink ode23tb to obtain the flow rate (Qi ) as a function of time. For simplicity,
the following valve and non-valve parameters were chosen to be constant for all four
lymphangions, Table 2.1.
Table 2.1. Parameter values used for simulation of four-vessel lymphangion network system.
Definition

Denote

Valve failure pressure

pfail

−1.8 × 104

dyn. cm−2

Valve failure slope

sfail

4.9 × 10−2

cm2 . dyn−1

Maximum valve resistance

R vx

1.2 × 107

dyn. cm−2
cm3 . s−1

Minimum valve resistance

R vn

600

dyn. cm−2
cm3 . s−1

Valve opening slope

sopen

0.04

cm2 . dyn−1

Valve opening pressure

popen

−70

dyn. cm−2

Fluid viscosity

μ

0.01

dyn. s
cm2

Lymphangion length

L

0.3

cm

Constitutive-relation constant (pressure)

Pdi

50

dyn. cm−2

Constitutive-relation constant (diameter)

Ddi

0.025

cm

Contraction frequency

f

0.5

Hz

Inlet pressure

pa

2275

dyn. cm−2

Outlet pressure

pb

2375

dyn. cm−2
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Value

Unit (CGS)

With other parameters like the lymphangion length (L) and the inlet and outlet pressure
(pa and pb ) kept constant, the flow rate (Qi ) depends on the maximum active tension (M) that
declines in the case of damaged lymph nodes, resulting a lower flow rate [32]. Hence, the
simulation included the following scenarios•

A constant external pressure (pei = 2100 dyn. cm−2 ) with maximum active tension
(M = 3.6 dyn. cm−1 ) that indicated an undamaged lymphatic system.

•

A constant external pressure (pei = 2100 dyn. cm−2 ) with lower values of maximum
active tension M = {3.0, 2.5, 2.0, 0.5} dyn. cm−1 that indicated a damaged lymphatic
system.
A variable external pressure with the lowest value of the maximum active tension (M =
0.5 dyn. cm−1 ) that indicated the application of pneumatic compression treatment for a
damaged lymphatic system. The sequence for the application of variable external
pressure is given by Figure 2.2.

External Pressure, Pe (dyn/cm2)

•

Pump 1
Pump 2
Pump 3
Pump 4

10500

8400
6300
4200
2100
0
0

20

Time (s)

40

60

Figure 2.2. Sequence for application of variable external pressure to vessel segments.
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The pumps operated between the initial external pressure of 2100 dyn. cm−2 and a
higher external pressure of 10000 dyn. cm−2. The external pressure sequence simulated a
typical compression technique applied by pneumatic pumps for upper extremity
lymphedema [20].

DESIGN OF COMPRESSION SUBSYSTEM
2.2.1. Compression Garment
The compression garment used for treating upper extremity lymphedema can have
multiple chambers. The number of chambers typically ranges from 3 to 12; however, there is no
uniform criteria for selection of this parameter [33]. In this study, a compression garment
consisting of four separate chambers was made, as depicted in Figure 2.3.

Figure 2.3. Chamber specifications of prototype compression sleeve.
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The chambers were cut from a single sheet of heat sealable, polymer-coated nylon fabric (Seattle
Fabric Inc., Seattle, Washington, USA) and sealed using an impulse sealer. The fabric was
chosen for its anti-microbial and fire retardant properties, and high thermal and chemical stability
[34]. Adjustable straps (VELCRO, Manchester, New Hampshire, USA) were sewn onto the
outside so the sleeve could be easily attached and removed.
2.2.2. Pneumatic Pumps
Four 22K series 4.5 V DC-motor-driven gas diaphragm pumps manufactured by Boxer
GmbH (Ottobeuren, Germany) were used for applying compression to the chambers. Each pump
was rated for a maximum pressure of 300 mbar (225 mmHg). The outlet valves of the pumps
were connected to the compression garment chambers by a silicone rubber tube with an outer
diameter of 6.50 mm and an inner diameter of 3.50 mm. The silicone rubber tube was glued to
each of the four chambers that enabled the chambers to inflate and deflate separately, Figure 2.4.

Figure 2.4. Schematic of four compression chambers connected to pneumatic pumps.
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2.2.3. Sequential Operation of Pumps
A compression circuit system was built for a sequential maneuver of the pumps for a total
duration of 180 seconds that indicated one full compression cycle, Figure 2.5. The compression
cycle was divided into four phases. Phase 1 denoted the operation of Pump 1 from 0 to 30
seconds. Phase 2 denoted the operation of Pump 1 and Pump 2 from 30 to 60 seconds. Phase 3
denoted the operation of the first three pumps from 60 to 90 seconds and Phase 4 denoted the
operation of all four pumps from 90 to 180 seconds.

Figure 2.5. Sequential operation of pumps for a total duration of 180 seconds.
The sequential operation inflated the chambers one by one from proximal (upper arm) to
distal (lower arm) with the maximum pressure in a chamber not to exceed 60 mmHg [35]. With
this setup, a time versus pressure curve was obtained as each chamber reached a pressure of 10,
20, 30, 40, and 50 mmHg. A voltage versus pressure curve was also obtained for the chambers.

DESIGN OF BIA SUBSYSTEM
Performing a BIA analysis typically includes a hand-to-hand mode or a foot-to-foot mode
in which the path of current flows through respective limbs [36]. The procedure involves
attaching a number of contact electrodes to measure body impedance values. By combining hand
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and foot contact plates with a fixed measuring circuit, a multi-segmental impedance
measurement system can also be developed for a BIA analysis.
2.3.1. Development of Test Circuit
A test circuit equivalent to the human arm model was developed as a part of designing
the BIA subsystem, Figure 2.6 [37]. Resistors R1 and R4 modeled the resistance of the electrodeskin interface. Resistors R2 and R3 modeled the intra-cellular fluid (ICF) and extra-cellular fluid
(ECF) respectively (see Figure 1.5) and are mentioned as the ‘test circuit impedance’ throughout
this study. The cell membrane capacitor C1 was in series with ICF resistor R2 and parallel with
ECF resistor R3.

Figure 2.6. Schematic of test circuit used in BIA subsystem.
The test circuit impedance is a frequency-dependent variable impedance with a resistive
(real) part and a reactive (imaginary) part. At very low frequency, the cell membranes act as an
effective barrier to AC current that makes the current to pass around the cell membranes (refer to
Figure 1.5). For a very high frequency, the current passes directly through the cell membrane and
no capacitance is observed. At medium range frequencies, the cell membranes act as capacitors
and the phase differences between the current intensity and voltage drop are observed. In
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practice, the phase difference for biological tissues are typically below 10 degrees or 0.17 rad
[38].
For the BIA subsystem, an initial test circuit included an ECF and ICF impedance of 82
Ω (denoted by Z82). Measured at zero frequency with a calibrated LCR meter (B&K Precision
Model 894, Yorba Linda, California, USA) [39], the actual DC resistance for Z82 was 81.81 Ω.
Measured in the limit as frequency increases, the test circuit impedance theoretically decreases to
a limiting value of 41 Ω. Practically, parasitic effects mean that at extremely high frequencies,
inductive effects take over, increasing the total impedance. The change in impedance with
varying frequency was measured with the LCR meter.
2.3.2. Relationship between ECF Volume and ECF Resistance
The relationship between ECF volume (VECF ) and ECF resistance (or in this case, test
circuit impedance) (Z) can be given by the following equation [38], [40]2/3

VECF

H 2 √W
= k ECF (
)
Z

(7)

where H and W are the height and weight of the individual expressed in cm and kg respectively.
The factor k ECF depends on ECF resistivity (ρECF ) expressed in Ω-cm, and body density (Db )
g

expressed in cm3. The value of k ECF can be further calculated by the following equation1/3

k ECF

1 K B 2 ρECF 2
=
(
)
100
Db

(8)

where K B is a factor based on approximation of individual geometry. For measurements of VECF ,
k ECF can be approximated as 0.306 for men and 0.316 for women [40]. A 3% change in VECF can
be an indication of lymphedema related swelling [41].
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2.3.3. Development of BIA Circuit
A BIA circuit was built to provide single and multi frequency impedance measurements
of the test circuit, Figure 2.7. The circuit performance was simulated using TINA-TI analog
electronic circuit simulator.

Figure 2.7. Schematic of BIA circuit developed for impedance measurements of a test
circuit.
A virtual ground circuit was used to create a mid-supply rail, consisting of a resistor
divider and op-amp follower (OPA 340, Texas Instruments) in a unity gain configuration. Thus,
for the signal conditioning circuitry, the power supply system consisted of a high-side supply of
+2.5 V and a low-side supply of -2.5 with the virtual ground in between. The 5 V power input
was provided by a Zeee 5200 mAh 7.4 V battery (Zeee Power, Houizhou, Guangdong, China).
An OPA 340 op-amp was used as the basis of a Howland current source circuit in the
BIA subsystem. The positive and negative feedback paths of the Howland circuit were balanced
through a matched resistor array consisting of four resistors (R11 to R13) of 100 kΩ
(ORNTA1003AT1, Vishay Intertechnology) with a precision of ±0.1%. As a result, a voltage23

controlled current source was obtained [42]. A resistor of 500 Ω was placed across the Rg pins
(R16 and R17) of the in-amps to achieve a differential gain of G = 99.8, [43]. This gain value
was used to achieve a high common-mode rejection ratio (CMRR) which can be represented by
the following equationAd
Ad 2
Ad
CMRR = (
) = 10 log10 (
) dB = 20 log10 (
) dB
|ACM |
|ACM |
|ACM |

(9)

Here, Ad is the differential gain (G) and ACM is the common-mode gain. Hence, a high value for
Ad ensured the amplification of required differential signals while rejecting unwanted commonmode signals. A final gain stage was implemented with an inverting amplifier (OPA 340) with a
gain of 18 [44]. Two instrumentation amplifiers (INA 821, Texas Instruments) measured the
output voltage drops across both the test circuit impedance (Z82) and a known reference
impedance (R15) of 50 Ω placed in series with the test circuit impedance.
The maximum voltage that could be supplied to the circuit was limited by the 7.4 V
voltage of the battery. The use of a 200 kΩ resistor (R14) reduced the possibility of a large
current development in the test circuit. Moreover, a very low probabilty of short-cricuit failure
mode for film type resistors [45] enhanced the safety features of the circuit.
2.3.4. BIA Subsystem for Single Frequency Impedance Measurement
2.3.4.1. Configuration of Microcontroller as Signal Generator
An Arduino UNO Rev3 microcontroller board based on an 8-bit ATmega328P-PU
microcontroller was used to generate a pulse-width modulation (PWM) signal for the BIA circuit
in a ‘Phase and Frequency Correct’ mode [46], [47], Figure 2.8. The PWM signal frequency
(fPWM) was calculated by using the following equation-
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fPWM =

fCLK
2 × Np × TOP

(10)

Here, fCLK is the 16 MHz clock frequency of the microcontroller, Np is the prescaler divider
value and TOP is the timer/counter top set in the Input Capture Register 1 (ICR1) of the
microcontroller. With the 16-bit timer, the highest TOP value of 0xFFFF or 65536 was obtained
from ICR1. For a presecaler divider (Np ) value of 1, a 122.07 Hz PWM frequency (fPWM) was
obtained.

Figure 2.8. Use of ATmega328P-PU as signal generator for BIA circuit.
The hexadecimal representation of the final fuse configuration for the microcontroller is
given by the followingLow- 0xBF
High – 0xDE
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Extended- 0x05
The internal 10-bit analog-to-digital converter (ADC) of the microcontroller was used to convert
the analog signal into a digital signal.
The analog input pin PC0 of the microcontroller recorded the voltage drop across the test circuit
impedance whereas the analog input pin PC1 recorded the voltage drop across the reference
impedance.
2.3.4.2. Calculating Fourier Coefficients of Signal Frequency
The Fourier coefficient for a measured signal x(t) sampled at times iΔt, (i = 1, … , N) can
be approximated by the following rectangular-windowed discrete transformN

2
cN = ∑(cos(2πfb iΔt) + i sin(2πfb iΔt))x(iΔt)
N

(11)

i=1

In the above equation, the number of samples N was selected as
N ∈ {100, 200, 500, 1000, 2000, 5000}
for the calculation of Fourier coefficient. The number of samples is a tradeoff between the time
to finish the measurement and the accuracy. Considering a partial sum to find a recursive
algorithm for computation of cN , the Fourier coefficient was calculated ascj =

=

2 j−1
(
c + (cos(2πfb jΔt) + i sin(2πfb jΔt))x(jΔt))
j
2 j−1

(12)

j−1
2
cj−1 + (cos(2πfb jΔt) + i sin(2πfb jΔt))x(jΔt)
j
j

The Coordinate Rotation Digital Computer (CORDIC) algorithm was used to calculate
trigonometric functions in the above Fourier coefficients formula [48]. With the time sampling
interval (Δt) set at 25 μs, the algorithm was formulated to calculate the Fourier coefficient of the
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PWM signal frequency of 122.07 Hz and a sampling frequency of 500 Hz. A total of 20
measurements were obtained for each number of samples (N).
A fixed-point arithmetic was used for the ATmega328P-PU microcontroller to perform
required computations and ensure that calculations can be performed at the required sample rates
[47]. A fixed-point arithmetic library, AVRfix was used for all fixed-point calculations. Based on
the ISO/IEC 18037 standard, the signed _Accum s15.16 bit fixed-point data type was used for
calculations[49].
2.3.4.3. Calculations of Ratio of Amplitudes and Phase Difference between Output Signals
The output of the discreet Fourier transform algorithm consists of a real part (Re) and an
imaginary part (Im). The ratio of amplitude of the output signals (γ) was calculated by using the
following equationsAmplitude of output signal obtained from analog input pin PC0 (γ1 ) = √(Re)1 2 + (Im)1 2
Amplitude of output signal obtained from analog input pin PC1 (γ2 ) = √(Re)2 2 + (Im)2 2
Ratio of amplitude (γ) =

γ1
γ2

The phase difference (Φ) between the two output signals was also obtained by using the
following equationsPhase of output signal obtained from analog input pin PC0 (Φ1 ) = atan (

Im1
)
Re1

Phase of output signal obtained from analog input pin PC1 (Φ2 ) = atan (

Im2
)
Re2

Phase difference (Φ) = |Φ1 − Φ2 |
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Using the above equations, the mean values of ratio of amplitudes (γ) and phase difference (Φ)
were obtained for the specified number of samples (N). The accuracy of measurements was
estimated based on a 95% confidence interval for the 20 data points.
2.3.4.4. Comparison between Test Circuit Impedance and Measured Impedance
The ratio of output signal amplitudes (γ) was multiplied by the reference impedance
(50 Ω) to measure the impedance of the body (or, in this case, a phantom test circuit). To
compare the measured impedance with the test circuit impedance, the following set of nine
variable test circuit impedance (measured by a high accuracy LCR meter at zero frequency) were
considered for the BIA subsystem along with the initial impedance of Z82Denote

Z74

Z76

Z78

Z80

Z82

Z84

Z86

Z88

Z90

Z (Ω)

74.05

75.95

77.78

80.22

81.81

83.56

86.06

88.21

90.34

For each of the nine test circuit impedances, the standard value of ratio of amplitude (γ) was
calculated based on the 50 Ω reference impedance. A percentage of error between the test circuit
impedance and the measured impedance was obtained for specified number of samples (N). The
percentage of error was averaged over N to get the error range for all nine test circuit impedance
values.
2.3.4.5. Sensitivity Analysis of Measured Impedance
The percentage of error between the test circuit impedance and the measured impedance
was used to analyze the sensitivity of the BIA circuit. For an average percentage of error in
measured impedance, the corresponding error in ECF volume was calculated based on equations
(7) and (8). The range of error was then used to determine the sensitivity of the BIA circuit that
could be used for detection of swelling.
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2.3.5. BIA Subsystem for Multi frequency Impedance Measurement
2.3.5.1. Multiple Frequency Testing
A Mixed Signal Oscilloscope (Keysight InfiniiVision MSOX3024T) was used to capture
the output signals from the two instrumentation amplifiers, Figure 2.9. The oscilloscope’s builtin waveform generator was set to generate square waves of frequencies
f = {100, 500, 1k, 5k, 10k, 20k, 40k, 60k, 80k, 100k} Hz
across the inputs to the Howland circuit.

Figure 2.9. Use of oscilloscope as signal generator for BIA circuit.
Channel 1 of the oscilloscope measured the voltage drop across the reference impedance (50 Ω)
whereas Channel 2 measured the voltage drop across the test circuit impedance (Z74 to Z90).
2.3.5.2. Generation of Nyquist Plot
The waveform data obtained from oscilloscope was imported to MATLAB and the
Fourier coefficients of the periodic voltage measurements of the test circuit resistance at
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frequency fi , labeled R i , and the test circuit reactance at frequency fi , labeled X i , were calculated
at each of the test frequencies to generate the Nyquist plot. The MATLAB trapezoidal numerical
integration method was used to calculate the Fourier coefficients for signals obtained from
Channel 1 and Channel 2 of the oscilloscope with a sampling time dt = 8 × 10−10 seconds. The
following equations describe the calculation, where τ is the signal period.
Nτ

Ai = ∫ ejωi t Vref (t) dt

(13a)

0
Nτ

Bi = ∫ ejωi t Vtest (t) dt

(13b)

0

ωi = 2πfi
R i + jXi =

Bi
R
Ai ref

(13c)
(13d)

The Nyquist plot was validated by using the calibrated LCR meter that measured the
resistance and reactance of the test circuit at the same signal frequencies with 4-wire Kelvin
clips. A comparison was made between the prototype BIA measurements and LCR meter
measurements of test circuit impedance at room temperature (72 F) over the specified frequency
range. The comparison was based on the ‘Magnitude Ratio’ that can be calculated by the
following equation-

Magnitude ratio (m) =

Test circuit impedance magnitude obtained from prototype
Test circuit impedance magnitude measured by LCR meter
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2.3.5.3. Temperature Stability
The temperature stability of the BIA circuit was examined to observe changes in the
Nyquist plot for test circuit impedance Z74 at temperatures higher than the room temperature (72
F) to simulate potential variability in the environment of the measurement device. A hot plate
was used to slowly heat the BIA circuit until the temperature reached the target values of T =
{75, 80, 85, 90} F. Once the target temperature was reached, the oscilloscope was used to obtain
waveform data. Voltage drops across the reference impedance and the test circuit impedance
were captured to generate Nyquist plots similar to the previously described method.

CALCULATION OF BATTERY LIFE AND NUMBER OF COMPRESSION CYCLES
Both the compression subsystem and the BIA subsystem were powered by a Zeee 5200
mAh 7.4 V battery. For the compression subsystem, the four phases (p = 1, 2, 3, 4) contributed
to the average current draw over one compression cycle of 180 seconds. An ammeter was used to
measure the average current draw at each of the four phases. The weighted average for
compression subsystem (Iavg−compression) was calculated by the following equationIavg−compression =

∑4p=1 I × Tp
p

(14)

180

where Ip is the average current draw by phase p and Tp is the duration of phase p.
For the BIA subsystem, the Arduino board (Iavg−arduino ), microcontroller (Iavg−microcontroller ),
and Howland circuit (Iavg−Howland ) contributed to the average current draw (Iavg−BIA ) over one
compression cycle of 180 seconds. The weighted average was calculated by the following
equationIavg−BIA = Iavg−arduino + Iavg−microcontroller + Iavg−Howland

31

(15)

The average power draw by the compression subsystem and the BIA subsystem was
calculated based on the average current draw over one compression cycle by those subsystems
and the supply voltage. The battery life was calculated based on the battery capacity and the total
average power draw over one compression cycle by the subsystems. The estimated total number
of compression cycles was calculated based on the battery life and the duration of each
compression cycle.

32

RESULTS AND ANALYSIS
LYMPHATIC SYSTEM
Figure 3.1 shows the flow rates (Qi ) obtained from five valves (i = 1, 2, 3, 4, 5) for a
maximum active tension M = 3.6 dyn. cm−1 and a constant external pressure pe =
2100 dyn. cm−2 , indicating an undamaged lymphatic system. The value of the maximum flow
rate ranged between 1.36 cc/hr for Q1 and 0.65 cc/hr for Q5 .

Figure 3.1. Flow rates obtained from different valves of lymphangion chain network for a
maximum active tension M = 3.6 dyn. cm−1 and a constant external pressure pe =
2100 dyn. cm−2.
Figure 3.2 shows the changes in flow rate Q5 observed in the last valve (i = 5) of the
lymphangion chain network for different values of maximum active tension (M). As the tension
decreased from M = 3.6 dyn. cm−1 to M = 0.5 dyn. cm−1 (indicating damage to the lymphatic
system), the flow rate reduced from 0.65 cc/hr to 0.05 cc/hr.
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Figure 3.2. Changes in flow rate observed in the last valve (i = 5) of the lymphangion chain
network as the maximum active tension (M) reduced from 3.6 dyn. cm−1 to 0.5 dyn. cm−1 .
Figure 3.3 shows the flow rate Q5 observed for the lowest value of the maximum active
tension (M = 0.5 dyn. cm−1 ) under the application of an additional variable external pressure
(see Figure 2.2) that indicated a typical pneumatic compression treatment sequence. The data
was compared to the flow rate obtained for a constant external pressure pe = 2100 dyn. cm−2 .
An average of 19% increase in flow rate was observed in the case of the additional variable
external pressure.
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Figure 3.3. Comparison of flow rate (Q5 ) between an additional variable external pressure
(pneumatic compression) and a constant external pressure (no pneumatic compression) for the
lowest value of maximum active tension.

COMPRESSION SUBSYSTEM
Table 3.1 shows the maximum pressure measured at each compression chamber for one
full compression cycle of 180 seconds. The maximum pressure in the chambers ranged between
53.1 mmHg and 54.0 mmHg. It was observed that once reached, the maximum pressure was
maintained by all four chambers throughout the duration of operation.
Table 3.1. Maximum pressure measured at each compression chamber for a compression cycle
of 180 seconds.
Maximum Pressure (mmHg)
Chamber 1

53.1

Chamber 2

53.1

Chamber 3

54.0

Chamber 4

53.6
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Figure 3.4 shows the time required for individual chambers to reach 10, 20, 30, 40, and
50 mmHg of pressure. The average time required for the chambers to reach 50 mmHg pressure

Time (s)

was 75 seconds.
100
90
80
70
60
50
40
30
20
10
0

Chamber 1
Chamber 2
Chamber 3
Chamber 4

0

10

20

30
40
Pressure (mmHg)

50

60

Figure 3.4. Time required for four pneumatic compression chambers to reach target pressure.
Figure 3.5 shows the voltage vs pressure curve for the chambers. The highest pressure of
117 mmHg was observed in Chamber 1 for a 6 V supply whereas the lowest pressure of 6 mmHg
was observed in Chamber 3 for a 4 V supply. All four chambers had a pressure range of 50
mmHg to 60 mmHg for a supply of 5 V.
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Figure 3.5. Voltage vs pressure curve for four pneumatic compression chambers. The supply
voltage ranged from 4 V to 6 V.

BIA SUBSYSTEM
3.3.1. Single Frequency Impedance Measurement
Figure 3.6 to Figure 3.14 show the mean values of ratio of amplitudes (γ) and phase
difference (Φ) between two output signals. The measurements were taken at number of samples
N ∈ {100, 200, 500, 1000, 2000, 5000} for variable test circuit impedance Z74 to Z90. The
standard value of γ calculated from the reference impedance (50 Ω) and test circuit impedance is
also shown in the figures.
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Figure 3.6. Mean of ratio of amplitudes and phase difference for Z74.

Figure 3.7. Mean of ratio of amplitudes and phase difference for Z76.

Figure 3.8. Mean of ratio of amplitudes and phase difference for Z78.
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Figure 3.9. Mean of ratio of amplitudes and phase difference for Z80.

Figure 3.10. Mean of ratio of amplitudes and phase difference for Z82.

Figure 3.11. Mean of ratio of amplitudes and phase difference for Z84.
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Figure 3.12. Mean of ratio of amplitudes and phase difference for Z86.

Figure 3.13. Mean of ratio of amplitudes and phase difference for Z88.

Figure 3.14. Mean of ratio of amplitudes and phase difference for Z90.
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Table 3.2 shows the comparison between the test circuit impedance and measured
impedance. For all nine measurements, the average percentage of error in measured impedance
ranged from 1.26% to 1.67%.
Table 3.2. Comparison between Test Circuit Impedance and Measured Impedance (Averaged
Over Six Different Number of Samples, N).
Denote

Test Circuit Impedance (Ω) Measured Impedance (Ω)

Avg. Error (%)

Z74

74.05

75.17

1.51

Z76

75.95

77.16

1.59

Z78

77.78

79.03

1.61

Z80

80.22

81.47

1.56

Z82

81.81

82.84

1.26

Z84

83.56

84.85

1.54

Z86

86.06

87.28

1.42

Z88

88.21

89.48

1.44

Z90

90.34

91.85

1.67

Table 3.3 shows the calculated average percentage of error in ECF volume (VECF ) based
on the error in measured impedance obtained from Table 3.2. Considering the average height of
161.50 cm and the average weight of 76.40 kg for American women of 20 years and older [50],
[51], the calculated average percentage of error in measured ECF volume ranged from 0.83% to
1.10%.
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Table 3.3. Percentage of Error in Measured ECF Volume based on Error in Measured
Impedance.
Denote Avg. Error in Measured Impedance (%)

Avg. Error in Measured ECF Volume (%)

Z74

1.51

0.99

Z76

1.59

1.05

Z78

1.61

1.06

Z80

1.56

1.03

Z82

1.26

0.83

Z84

1.54

1.01

Z86

1.42

0.94

Z88

1.44

0.95

Z90

1.67

1.10

3.3.2. Multi frequency Impedance Measurement
Figure 3.15 shows the Nyquist plot obtained from both the prototype BIS circuit and the
LCR meter at room temperature (72 F) for frequencies in the following set:
f = {100, 500, 1k, 5k, 10k, 20k, 40k, 60k, 80k, 100k} Hz
As the frequency increased (counter-clockwise direction), the real and imaginary parts
(resistance and reactance) of the output signal resulted a semi-circular shape.
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(c) Nyquist plot obtained for Z78.
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(d) Nyquist plot obtained for Z80.
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(a) Nyquist plot obtained for Z74.
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(e) Nyquist plot obtained for Z82.
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(f) Nyquist plot obtained for Z84.

(figure cont’d)
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(h) Nyquist plot obtained for Z88.
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(i) Nyquist plot obtained for Z90.
Figure 3.15. Nyquist plot obtained from prototype BIA measurements and LCR meter
measurements for nine test circuit impedance values (Z74 to Z90). The frequency increased from
100 Hz to 100 kHz in a counter-clockwise direction.
Figure 3.16 shows the magnitude ratio (m) between the prototype BIA measurements and
the LCR meter measurements for nine test circuit impedance (I74 to I90) over the frequency range
𝑓 = {100, 500, 1k, 5k, 10k, 20k, 40k, 60k, 80k, 100k} Hz. It was observed that on an average,
the test circuit impedance obtained from BIA measurements was 1.03 times higher than that of
the LCR meter.
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Figure 3.16. Magnitude ratio of test circuit impedance obtained from prototype BIA
measurements and LCR meter measurements over the frequency range 𝑓 =
{100, 500, 1k, 5k, 10k, 20k, 40k, 60k, 80k, 100k} Hz.
The Nyquist plots obtained for test circuit impedance of 74 Ω (Z74) at temperatures T =
{72, 75, 80, 85, 90} F are presented in Figure 3.17. For a total of five temperature values

Reactance (Ohm)

including the room temperature of 72 F, no significant changes in Nyquist plots were observed.
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Figure 3.17. Nyquist plots obtained for test circuit impedance, Z74 at five different temperature
values.
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BATTERY LIFE AND NUMBER OF COMPRESSION CYCLES
Table 3.4 shows the average power draw by the compression subsystem over one
compression cycle of 180 seconds. An average current draw of 246 mA was measured over one
compression cycle. For a 5 V supply voltage, an average power draw of 1230 mW was
calculated.
Table 3.4. Calculation of Average Power Draw by Compression Subsystem over One
Compression Cycle (180 Seconds).
Phase 1

Phase 2

Phase 3

Phase 4

Avg. Current Draw (mA)

108

177

246

315

Duration (seconds)

30

30

30

90

Avg. Current Draw over One Cycle (mA)

246

Supply Voltage (V)

5

Avg. Power Draw over One Cycle (mW)

1230

Table 3.5 shows the average power draw by the BIA subsystem. An average current draw
of 112 mA by all three components was measured for one compression cycle. For a 5 V supply
voltage, an average power draw of 560 mW was calculated.
Table 3.5. Calculation of Average Power Draw by BIA Subsystem over One Compression Cycle
(180 Seconds).

BIA Subsystem

Component

Avg. Current Draw over One Cycle (mA)

Arduino Board

50

(table cont’d)
46

BIA Subsystem

Component

Avg. Current Draw over One Cycle (mA)

Microcontroller

12

Howland Circuit

50

Avg. Current Draw over One Cycle by All

112

Components (mA)
Supply Voltage (V)

5

Avg. Power Draw over One Cycle (mW)

560

Table 3.6 shows the approximate battery life of the Zeee 5200 mAh 7.4 V battery. The
battery life of 21.4 hours was calculated based on the total average power draw by the
compression and the BIA subsystem for one full compression cycle. Based on the total battery
life and duration of one compression cycle, a total of 429 compression cycles can be achieved.
Table 3.6. Calculation of Battery Life and Number of Compression Cycles.
Total Avg. Power Draw over One Compression Cycle (mW)

1790

Battery Capacity (mWh)

38480

Battery Life (h)

21.4

Total Number of Compression Cycles

429
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DISCUSSION
LYMPHATIC SYSTEM
The relationship between the maximum active tension (M) and flow rate (Q5 ) obtained
from simulation of the lymphangion chain network agreed with the work of Bertram et. al [32].
For a constant external pressure (pe ), as the maximum active tension decreased, the flow rate
reduced. However, it was observed that under the application of an additional variable external
pressure indicating a typical pneumatic compression treatment sequence, the peak flow rate
increased by 19%. Hence, the application of sequential compression provided by pneumatic
pumps is likely to enhance the lymphatic flow for a damaged lymphatic system.

COMPRESSION SUBSYSTEM
It was observed that the small pneumatic pumps selected, which are of suitable size for a
fully portable device, could provide the pressure required during a timeframe that is reasonable
and comparable to sequential compression routines in commercially available devices [52]. For a
treatment duration of 180 seconds, pressure as high as 54 mmHg, which is greater than what is
typically needed, was obtained. It was observed that once reached, the maximum pressure was
maintained by all four chambers for the rest of the simulated treatment protocol. The average
time required by the chambers (75 seconds) to reach maximum pressure allowed a steady
inflation.
However, the voltage vs pressure data for the chambers suggested that the voltage input
may not be a reliable way to determine the applied pneumatic pressure provided by small pumps,
although the pressures were much more consistent at 5 V than at other voltages. A potential
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solution to this problem is the addition of pressure sensors and a feedback control system to
regulate the applied pressure during compression therapy.
Duration of treatment could be varied as required through programming of the on-time
and off-time of each pump. This would allow adjustments of the inflation time for each chamber
[53]. The number of compression cycles can be determined based on the treatment duration and
recommended hours of treatment per day. Presumably a physician or licensed therapist would
determine the treatment plan in conjunction with the available scientific evidence. A more
localized compression can be achieved by increasing the number of chambers and changing their
configurations [54]. However, assessment should be made for each individual to determine the
pressure level for the chambers [22].
The heat sealable coated nylon fabric showed no signs of wear and tear after multiple
tests. This makes the material a good candidate for use as compression chambers. No air leakage
was observed during the experiments, suggesting that an impulse sealer is an effective tool for
manufacturing the air chambers.

BIA SUBSYSTEM
The measured impedance obtained by multiplying the ratio of amplitude (γ) and reference
impedance (50 Ω) was close to the test circuit impedance. The range for average percentage of
error in measured impedance (1.26% to 1.67%) provided an expected error range of 0.83% to
1.10% in ECF volume [refer to equation (5)]. Hence a the BIA subsystem should be sensitive
enough to detect a 3% change in ECF volume which is an indication of swelling in a
lymphedema affected arm [41]. The Nyquist plots obtained from the oscilloscope for frequency
range f = {100, 500, 1k, 5k, 10k, 20k, 40k, 60k, 80k, 100k} Hz matched with the ones obtained
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from the LCR meter. For lower frequencies (100 Hz to 10 kHz), the average magnitude ratio (the
ratio of test circuit impedance between prototype BIA measurements and LCR meter
measurements) of was around 1.01. However, as the frequency increased (from 20 kHz to 100
kHz), the magnitude ratio went up. At 100 kHz, the average magnitude ratio was around 1.08.
This suggests that the Nyquist plot obtained by the oscilloscope have a slightly larger deviation
from the plot obtained by the LCR meter at higher frequencies. No significant changes in
Nyquist plots were observed at T = {72, 75, 80, 85, 90} F for test circuit impedance of 74 Ω
(Z74). This suggests that the BIA circuit should work properly within a temperature range of 72 F
to 90 F.
From the Nyquist plots it was observed that the impedance decreases with increasing
frequency. This is consistent with the theory since the high-frequency current passes directly
through the cell membranes and hence take a shorter route. The plot can provide information on
total body water (TBW), extra-cellular fluid (ECF), and tissue mass. In particular, because the
ECF measurement is a known diagnostic signal for lymphedema [55], it can serve as a useful
signal for feedback control. The data can be made accessible through a wireless connection in
future work.

BATTERY LIFE AND PORTABILITY
It was observed that the Zeee 5200 mAh 7.4 V battery has an approximate battery life of
21.4 hours for the integrated compression and BIS system. Considering a daily compression
treatment for 45 minutes [22], each battery can last up to 28 days. It was observed that a total of
429 compression cycles (180 seconds for each compression cycle) can be achieved with the
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battery. However, the duration of each compression cycle is likely to vary based on individual
needs prescribed by their physicians.
The compression system carrying the pumps, circuit, and battery is sized to fit in a fanny
pack that goes around the waist of the person, Figure 4.1. This is likely to enhance mobility by
allowing freedom of movement. The lightweight, wearable sleeve is also expected to provide
greater comfort, in comparison to the more rigid materials of traditional compression garments,
during the course of the treatment. However, some precautions should be taken as the mobility of
the arm undergoing compression could be affected while the sleeve is pressurized, potentially
increasing the risk of some activities (e.g. preparing food with a knife, carrying a lit candle, etc.).

Figure 4.1. Pneumatic compression system carrying pumps, circuit, and portable battery.
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CONCLUSION
The prototyping efforts aimed at producing a smart, portable, mechatronic compression
system for treatment of lymphedema were described. A lymphatic system with four lymphangion
chain network was simulated to observe changes in flow rate for different values of maximum
active tension in lymphatic muscles and external pressure. Small battery-operated pneumatic
pumps were tested and determined to provide the required pressure and flow rate for pneumatic
compression therapy. A heat sealable, polymer-coated nylon fabric was selected and used to
construct a compression therapy sleeve for the prototype. A BIA system was built and tested on
phantom electrical models of the human arm varying in a manner consistent with the variation in
electrical properties during swelling. The microcontroller-based single frequency BIA system
was designed to obtain complex impedance measurements of the arm through a non-invasive
interface. A benchtop LCR meter validated the measurements to be within the permissible range
for detection of changes in arm volume. In the multi frequency BIA system, the frequency and
phase responses of the phantom test circuit were characterized by Nyquist plots with real
(resistance) and imaginary (reactance) parts of impedance at varying waveform frequencies. The
Nyquist plots obtained for different test circuit impedance values were validated by a calibrated
LCR meter. For a temperature range of 75 F to 90 F, the BIA circuit can provide accurate
measurements of impedance.
For the integrated compression and BIA system, the Zeee 5200 mAh 7.4 V battery can
run up to 28 days with a daily compression treatment for 45 minutes. From a packaging
standpoint, the integrated compression sleeve could either be worn as an over-garment or be
specially designed into ‘lymphedema shirts’ (or pants for lower extremity), eliminating the need
to wear any additional garments. Combined with microprocessor-based sensing system and
52

control algorithms, the finished prototype should be lightweight and portable. The technology
can provide freedom of movement and reduce the discomfort associated with current devices.
Thus, the future work could lead to an “all-in-one” solution for pneumatic compression treatment
for lymphedema.
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FUTURE WORK
The present design has some aspects that need further improvement for future studies.
For instance, in the design of lymphatic system only the maximum active tension and external
pressure were varied to observe the changes in lymph flow. However, that is not the case in an
actual lymphatic system. There are other time-dependent variables like the length and diameter
of each lymphangion, transmural pressure, and contraction frequency that are present in the
system and can affect the lymph flow rate. Hence, a more detailed study of the lymphatic system
simulation is needed, taking into consideration the all of these other variables. A complete
lymphatic network system can eventually be modeled for upper and lower extremity of the body
prior to developing a pneumatic compression device. The will determine the suitable pressure
range for compression treatment of each individual.
The proposed compression subsystem used the voltage input obtained from voltage vs
pressure data for regulation of pressure in the compression chambers. However, a more reliable
way would be the use of pressure sensors as the method of regulating pressure provided by the
pneumatic pumps. This will also allow monitoring the changes in extra-cellular fluid (ECF)
volume to detect swelling. However, as mentioned earlier, the level of ECF volume that can
indicate swelling is likely to vary in every individual. Hence, an initial assessment of body
composition is required to obtain information on parameters like total body water (TBW) and
intra-cellular fluid (ICF) based on a ‘non-lymphedema’ control.
Enough data may eventually be accumulated to enable the application of dynamic
systems feedback control with the human as part of the controlled plant, therefore enabling a
precision medicine approach [56] to the management of lymphedema, Figure 6.1. Adaptive
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control laws or learning-based controllers may be applied to this human-in-the-loop system that
can optimally manage the prescription of treatment.

Figure 6.1. Flow chart of proposed integrated device based on feedback control system.
The finished product should be a single compression unit carrying the compression
sleeve, microcontroller, pneumatic pumps, and pressure sensors, Figure 6.2. The pumps will start
operating upon the detection of swelling. Once the swelling goes down, sensors will detect the
reduction and the pumps will stop.

Figure 6.2. Schematic of a potential smart pneumatic compression device.
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APPENDIX A. SIMULINK MODEL FOR LYMPHANGION CHAIN
NETWORK
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APPENDIX B. ARDUINO CODE FOR SEQUENTIAL OPERATION OF
PUMPS
int motor1Speed = 200;
int motor2Speed = 200;
int motor3Speed = 200;
int motor4Speed = 200;
int motorPin1 = 6;
int motorPin2 = 9;
int motorPin3 = 10;
int motorPin4 = 11;
long int stop1;
long int stop2;
long int stop3;
long int stop4;
void setup() {
stop1=millis()+30000; // n seconds
stop2=millis()+60000; // n seconds
stop3=millis()+90000; // n seconds
stop4=millis()+120000; // n seconds
}
void loop() {
if (millis()<stop1) {
analogWrite(motorPin1, motor1Speed);
} else {
analogWrite(motorPin1, motor1Speed);
if (millis()<stop2) {
analogWrite(motorPin2, motor2Speed);
} else {
analogWrite(motorPin2, motor2Speed);
if (millis()<stop3) {
analogWrite(motorPin3, motor3Speed);
} else {
analogWrite(motorPin3, motor3Speed);
if (millis()<stop4) {
analogWrite(motorPin4, motor4Speed);
} else {
analogWrite(motorPin4, motor4Speed);
if (millis()>stop4) {
analogWrite(motorPin1, 0);
analogWrite(motorPin2, 0);
analogWrite(motorPin3, 0);
analogWrite(motorPin4, 0);
}
}
}
}}
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APPENDIX C. ARDUINO CODE FOR SINGLE FREQUENCY
IMPEDANCE MEASUREMENT
//from http://sphinx.mythic-beasts.com/~markt/ATmega-timers.html
//The 16 modes are summarized in this table.
//code Mode TOP Update of OCR1x
TOV1 Flag Set
//0
Normal
0xFFFF
Immediate
MAX
//1
PWM, Phase Correct, 8-bit 0x00FF
TOP BOTTOM
//2
PWM, Phase Correct, 9-bit 0x01FF
TOP BOTTOM
//3
PWM, Phase Correct, 10-bit 0x03FF
TOP BOTTOM
//4
CTC OCR1A
Immediate
MAX
//5
Fast PWM, 8-bit
0x00FF
BOTTOM
TOP
//6
Fast PWM, 9-bit
0x01FF
BOTTOM
TOP
//7
Fast PWM, 10-bit
0x03FF
BOTTOM
TOP
//8
PWM, Phase and Frequency Correct ICR1 BOTTOM
BOTTOM
//9
PWM, Phase and Frequency Correct OCR1A
BOTTOM
BOTTOM
//10 PWM, Phase Correct ICR1 TOP BOTTOM
//11 PWM, Phase Correct OCR1A
TOP BOTTOM
//12 CTC ICR1 Immediate
MAX
//13 (Reserved)
//14 Fast PWM
ICR1 BOTTOM
TOP
//15 Fast PWM
OCR1A
BOTTOM
TOP
//Note that in PWM, Phase and Frequency Correct mode (8), the PWM frequency
// is calculated by
// f_clk / (2 * N * TOP )
// where N is the prescaler value and TOP is the timer/counter top set in ICR1
//
void timer1_setup (byte mode, int prescale, byte outmode_A, byte outmode_B, byte
capture_mode)
{
// enforce field widths for sanity
mode &= 15 ;
outmode_A &= 3 ;
outmode_B &= 3 ;
capture_mode &= 3 ;
byte clock_mode = 0 ; // 0 means no clocking - the counter is frozen.
switch (prescale)
{
case 1: clock_mode = 1 ; break ;
case 8: clock_mode = 2 ; break ;
case 64: clock_mode = 3 ; break ;
case 256: clock_mode = 4 ; break ;
case 1024: clock_mode = 5 ; break ;
default:
if (prescale < 0)
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clock_mode = 7 ; // external clock
}
TCCR1A = (outmode_A << 6) | (outmode_B << 4) | (mode & 3) ;
TCCR1B = (capture_mode << 6) | ((mode & 0xC) << 1) | clock_mode ;
}
void setup() {
// put your setup code here, to run once:
pinMode(9, OUTPUT);
pinMode(A0, INPUT);
pinMode(A1, INPUT);
Serial.begin(19200);
}
//Each time through the loop, we will calculate the Fourier coefficient once
// Assume a signal frequency of 100 Hz, and a sampling frequency of 500 Hz.
// Then the Fourier coefficient can be calculated over 2 cycles using N=1000 samples
//
//
void loop() {
// put your main code here, to run repeatedly:
//First we need to output a 100 Hz signal
/* Code to output approximately a 100 Hz signal using Timer/Counter 1 on pin 9 */
timer1_setup(0, 0, 0, 0, 0);
ICR1 = 1024; //results in just over 10 bit pwm resolution and frequency of 122.0703125
Hz
OCR1A = 512; //results in 50% duty cycle signal on pin 9
TCNT1=0;
timer1_setup(8, 64, 2, 0, 0);
//PWM Output will appear on pin 9 (OC1A)
/* Now collect the correct number of samples and calculate
the Fourier coefficients of analog A0 and A1 using
a rolling sum */
long i = 0; //sample number
long N = 1000; //Number of samples to acquire
long dt = 2500; //microseconds per sample
int chA0, chA1; //values to hold analog samples
_Accum chA0k, chA1k; //fixed point conversions of analog samples
_Accum Real0, Imag0, Real1, Imag1, Real2, Imag2;
Real1 = itok(0);
Imag1 = itok(0);
Real0 = itok(0);
Imag0 = itok(0);
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_Accum cosvk, sinvk;
_Accum phase = 0;
_Accum dphase = ftok( 2*3.14159265358979*122.0703125*0.0025 );
long lastt = micros();
long t = micros();
//we need to collect N samples
for (int i = 0; i < N; ++i )
{
while ((t = micros())-lastt < dt) {} //wait for the next sample time by doing
nothing
//collect the samples (as close to synchronous as possible)
chA0 = analogRead(A0); //range 0-1023
chA1 = analogRead(A1); //range 0-1023
//convert the measurements to fixed point
chA0k = itok(chA0);
chA1k = itok(chA1);
//update the phase angle of the transform
phase = phase + dphase; //fixed point arithmetic, phase update
//now calculate the sincos coefficients
sinvk = sincosk( phase, &cosvk ); //get the trig values
//calculate coefficients in recurrence relation
_Accum C1, C2;
C1 = divkD( itok(i), itok(i+1) );
C2 = divkD( itok(2), itok(i+1) );
Real0 = mulkD(Real0, C1) + mulkD( mulkD(cosvk, chA0k), C2 );
Imag0 = mulkD(Imag0, C1) + mulkD( mulkD(sinvk, chA0k), C2 );
Real1 = mulkD(Real1, C1) + mulkD( mulkD(cosvk, chA1k), C2 );
Imag1 = mulkD(Imag1, C1) + mulkD( mulkD(sinvk, chA1k), C2 );
lastt = t; //update the last loop timestamp
}
//At this point Real0 + i*Imag0 is the fourier coefficient of chA0 samples
//
Real1 + i*Imag1 is the fourier coefficient of chA1 samples
Serial.println("Values (Real0, Imag0, Real1, Imag1)");
Serial.println(ktod(Real0),5);
Serial.println(ktod(Imag0),5);
Serial.println(ktod(Real1),5);
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Serial.println(ktod(Imag1),5);
Serial.println();
delay(1000);
}
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